NIH-funded research P01 program project

Understanding how blood and vessel cells drive inflammation, clotting, and atherosclerosis

Official title: Cellular Mechanisms of Inflammation, Hemostasis, and Thrombosis

Funded at University of California, San Diego · NIH-11423184 · Data updated 2026-11-12

A large NIH grant aims to uncover how immune cells and blood vessels interact at the molecular level to influence inflammation, clotting, and heart disease, with findings that could lead to new treatments.

More Thrombosis research and trials

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2031
Funding year2026
Award (this year)$2,363,208
NIH project number2P01HL151433-06A1
Project IDNIH-11423184 on NIH RePORTER

Who could benefit from this research

Could help

Patients with atherosclerotic cardiovascular disease or vascular inflammation may benefit from future biomarker-guided therapies or preventive strategies.

Less likely to help

Individuals without ASCVD or vascular inflammatory conditions may not directly benefit from these findings.

What this research studies

This program will study how adhesion signals and immune pathways shape vascular inflammation and thrombosis. Four projects will test ideas about IL-2 signaling, a low-affinity form of a clotting receptor, chromatin changes in endothelial cells, and neutrophil adhesion. A core unit will help map where and how genes and proteins are active in blood and vascular cells inside tissues. The work combines advanced molecular imaging and multi-omic analyses to understand disease processes that contribute to ASCVD.

Why it matters

Potential benefit: If successful, the research could identify new biomarkers and targets to prevent or treat inflammatory vascular diseases and thrombosis.

How similar studies have gone: This approach builds on prior work in leukocyte signaling and endothelial biology, with a strong likelihood of yielding new mechanistic insights.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Ginsberg, Mark Howard — University of California, San Diego
  • Study coordinator: Ginsberg, Mark Howard

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.